# China NMPA Drug Inspection - Shantou Yuedong Pharmaceutical Co., Ltd. - Bupleurum chinense

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shantou-yuedong-pharmaceutical-co-ltd/1ea1fb96-ef05-4a6f-987e-dfa1665e8f08/
Source feed: China

> China NMPA drug inspection for Shantou Yuedong Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Bupleurum chinense. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Shantou Yuedong Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Bupleurum chinense
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/shantou-yuedong-pharmaceutical-co-ltd/d6fe368e-10cd-4477-af35-688991266f5d/